AAAAAA
Results:
1-21
|
Results: 21
Authors:
Masquelier, B
Chaix, ML
Burgard, M
Lechenadec, J
Doussin, A
Simon, F
Cottalorda, J
Izopet, J
Tamalet, C
Douard, D
Fleury, H
Mayaux, MJ
Blanche, S
Rouzioux, C
Citation: B. Masquelier et al., Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort, J ACQ IMM D, 27(2), 2001, pp. 99-104
Authors:
Touinssi, M
Gallian, P
Biagini, P
Attoui, H
Vialettes, B
Berland, Y
Tamalet, C
Dhiver, C
Ravaux, I
De Micco, P
De Lamballerie, X
Citation: M. Touinssi et al., TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load, J CLIN VIRO, 21(2), 2001, pp. 135-141
Authors:
Koch, N
Tamalet, C
Tivoli, N
Fantini, J
Yahi, N
Citation: N. Koch et al., Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase, J CLIN VIRO, 21(2), 2001, pp. 153-162
Authors:
Koch, N
Ndihokubwayo, JB
Yahi, N
Tourres, C
Fantini, J
Tamalet, C
Citation: N. Koch et al., Genetic analysis of HIV type 1 strains in Bujumbura (Burundi): Predominance of subtype C variant, AIDS RES H, 17(3), 2001, pp. 269-273
Authors:
Fantini, J
Tamalet, C
Yahi, N
Citation: J. Fantini et al., Secondary structure predictions of HIV-1 reverse transcriptase provide newinsights into the development of drug-resistance genotypes, AIDS, 15(9), 2001, pp. 1191-1192
Authors:
Koch, N
Yahi, N
Fantini, J
Tamalet, C
Citation: N. Koch et al., Mutations in HIV-1 gag cleavage sites and their association with protease mutations, AIDS, 15(4), 2001, pp. 526-528
Authors:
Gondois-Rey, F
Biancotto, A
Pion, M
Chenine, AL
Gluschankof, P
Horejsi, V
Tamalet, C
Vigne, R
Hirsch, I
Citation: F. Gondois-rey et al., Production of HIV-1 by resting memory T lymphocytes, AIDS, 15(15), 2001, pp. 1931-1940
Authors:
Masquelier, B
Race, E
Tamalet, C
Descamps, D
Izopet, J
Buffet-Janvresse, C
Ruffault, A
Mohammed, AS
Cottalorda, J
Schmuck, A
Calvez, V
Dam, E
Fleury, H
Brun-Vezinet, F
Citation: B. Masquelier et al., Genotypic and penotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase(RT): Multicenter study of patients treated with RT inhibitors, ANTIM AG CH, 45(6), 2001, pp. 1836-1842
Authors:
Yahi, N
Fantini, J
Tourres, C
Tivoli, N
Koch, N
Tamalet, C
Citation: N. Yahi et al., Use of drug resistance sequence data for the systematic detection of non-Bhuman immunodeficiency virus type 1 (HIV-1) subtypes: How to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale, J INFEC DIS, 183(9), 2001, pp. 1311-1317
Authors:
Yahi, N
Tamalet, C
Tourres, C
Tivoli, N
Fantini, J
Citation: N. Yahi et al., Mutation L210W of HIV-1 reverse transcriptase in patients receiving combination therapy - Incidence, association with other mutations, and effects onthe structure of mutated reverse transcriptase, J BIOMED SC, 7(6), 2000, pp. 507-513
Authors:
Burgard, M
Izopet, J
Dumon, B
Tamalet, C
Descamps, D
Ruffault, A
Vabret, A
Bargues, G
Mouroux, M
Pellegrin, I
Ivanoff, S
Guisthau, O
Calvez, V
Seigneurin, JM
Rouzioux, C
Citation: M. Burgard et al., HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment, AIDS RES H, 16(18), 2000, pp. 1939-1947
Authors:
Hubert, JB
Burgard, M
Dussaix, E
Tamalet, C
Deveau, C
Le Chenadec, J
Chaix, ML
Marchadier, E
Vilde, JL
Delfraissy, JF
Meyer, L
Rouzioux, C
Citation: Jb. Hubert et al., Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection, AIDS, 14(2), 2000, pp. 123-131
Authors:
Yahi, N
Tourres, C
Tivoli, N
Colson, P
Dhiver, C
Quinson, AM
Tamalet, C
Citation: N. Yahi et al., Evolution of HIV-1 multidrug-resistant genotypes during combination therapy and after the cessation of antiretroviral drugs, AIDS, 14(18), 2000, pp. 2943-2945
Authors:
Tamalet, C
Pasquier, C
Yahi, N
Colson, P
Poizot-Martin, I
Lepeu, G
Gallais, H
Massip, P
Puel, J
Izopet, J
Citation: C. Tamalet et al., Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection, J MED VIROL, 61(2), 2000, pp. 181-186
Authors:
Tamalet, C
Yahi, N
Tourres, C
Colson, P
Quinson, AM
Poizot-Martin, I
Dhiver, C
Fantini, J
Citation: C. Tamalet et al., Multidrug resistance genotypes (insertions in the beta 3-beta 4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: Incidence and association with other resistance mutations, VIROLOGY, 270(2), 2000, pp. 310-316
Authors:
Carrieri, MP
Tamalet, C
Vlahov, D
Yahi, N
Chesney, M
Moatti, JP
Citation: Mp. Carrieri et al., Relationship between HIV-1 viral load and continued drug use in untreated infected injection drug users, ADDICT BIOL, 4(2), 1999, pp. 197-202
Authors:
Thuret, I
Michel, G
Chambost, H
Tamalet, C
Giraud, P
Brunet, C
Perrimond, H
Citation: I. Thuret et al., Combination antiretroviral therapy including ritonavir in children infected with human immunodeficiency, AIDS, 13(1), 1999, pp. 81-87
Authors:
Koch, N
Yahi, N
Colson, P
Fantini, J
Tamalet, C
Citation: N. Koch et al., Genetic polymorphism near HIV-1 reverse transcriptase resistance-associated codons is a major obstacle for the line probe assay as an alternative method to sequence analysis, J VIROL MET, 80(1), 1999, pp. 25-31
Authors:
Koch, N
Yahi, N
Ariasi, F
Fantini, J
Tamalet, C
Citation: N. Koch et al., Comparison of human immunodeficiency virus type 1 (HIV-1) protease mutations in HIV-1 genomes detected in plasma and in peripheral blood mononuclear cells from patients receiving combination drug therapy, J CLIN MICR, 37(5), 1999, pp. 1595-1597
Authors:
Yahi, N
Tamalet, C
Tourres, C
Tivoli, N
Ariasi, F
Volot, F
Gastaut, JA
Gallais, H
Moreau, J
Fantini, J
Citation: N. Yahi et al., Mutation patterns of the reverse transcriptase and protease genes in humanimmunodeficiency virus type 1-infected patients undergoing combination therapy: Survey of 787 sequences, J CLIN MICR, 37(12), 1999, pp. 4099-4106
Authors:
Purgus, R
Tamalet, C
Poignard, P
Spire, B
George, F
Robert, A
Olmer, M
Citation: R. Purgus et al., Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient, TRANSPLANT, 66(10), 1998, pp. 1384-1386
Risultati:
1-21
|